PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 9 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $89,763,000 | -6.0% | 1,501,301 | -6.6% | 0.02% | -20.0% |
| Q1 2020 | $95,494,000 | -15.9% | 1,608,184 | -22.4% | 0.02% | +4.2% |
| Q4 2019 | $113,508,000 | +931.8% | 2,072,070 | +431.9% | 0.02% | +1100.0% |
| Q3 2019 | $11,001,000 | -16.7% | 389,582 | -2.1% | 0.00% | -33.3% |
| Q2 2019 | $13,205,000 | +50.2% | 397,865 | +53.9% | 0.00% | +50.0% |
| Q1 2019 | $8,791,000 | +11.0% | 258,553 | -10.6% | 0.00% | 0.0% |
| Q4 2018 | $7,920,000 | -21.1% | 289,146 | -15.9% | 0.00% | 0.0% |
| Q3 2018 | $10,043,000 | – | 343,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |